Pinnacle Medicines: Valuation, Funding & Investors
https://www.pinnaclemedicines.com/Therapeutics
Pinnacle Medicines is a biotechnology company developing oral peptide therapeutics using proprietary AI and physics-based discovery platforms. The company focuses on creating orally bioavailable peptide drugs and advancing a pipeline toward clinical proof-of-concept studies.
Leadership & Board
- Current Number of Employees
- 23
- Current LinkedIn Followers
- 2,940
Latest Estimated Valuation
- Total Amount Raised
- $89M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $89M
- Latest Funding Round
- Series B
Employee Trend
Pinnacle Medicines had 23 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
23Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Pinnacle Medicines had 2,940 followers as of November 2, 2026. The number of followers increased by 19 (0.65%) week-over-week.
2,940Latest Followers Count
19(0.65%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Mar 26, 2026 | Series B | $89.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| LAV | Series B |
| Foresite Capital | Series B |
| Quan Capital | Series B |
| HanKang Capital | Series B |
| RA Capital Management | Series B |
| Logos Capital | Series B |
| OrbiMed | Series B |
Similar Companies
A snapshot of private companies similar to Pinnacle Medicines, helping you discover and navigate related company profiles.
